Walmar Clinical ApS

CVR 43237381 · Private limited company (ApS) · Active · Low risk

Walmar Clinical ApS is a Private limited company (ApS), founded on , based in Snekkersten. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 932k and a net result of DKK 528k. CEO: Mikkel Walmar.

Bankruptcy risk for Walmar Clinical ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 44% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43237381
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Stolbjergvej 26C
3070 Snekkersten
Municipality
Helsingør
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio34.7%
Current ratio75%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 1.8mDKK 1.9m
Net profitDKK 528kDKK 623k
EquityDKK 932kDKK 666k
Total assetsDKK 2.7mDKK 2.4m
CashDKK 859k–
Short-term debtDKK 1.8m–
Tax owedDKK 90k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025178
1 Jan 2024 – 31 Dec 2024176
1 Jan 2023 – 31 Dec 2023180
3 May 2022 – 31 Dec 2022173

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMikkel WalmarCurrent
Owner (100%)26c Holding ApSCurrent
Owner (50%)Mikkel Walmar
Owner (50%)Pernille Gry Hansen
FounderMikkel WalmarCurrent
FounderPernille Gry HansenCurrent

The CEOs' other companies

Mikkel Walmar – 3 other companies

Address history (0 moves)

Stolbjergvej 26C, 3070 Snekkersten

Other companies at the same address

Similar companies in Helsingør

Questions and answers about Walmar Clinical ApS

Has Walmar Clinical ApS gone bankrupt?

No, Walmar Clinical ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Walmar Clinical ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of Walmar Clinical ApS?

Mikkel Walmar is the CEO of Walmar Clinical ApS.

When was Walmar Clinical ApS founded?

Walmar Clinical ApS was founded on 3 May 2022.

What is the equity of Walmar Clinical ApS?

Equity was DKK 932k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.